Log In
Print
BCIQ
Print
Print this Print this
 

Risperdal, risperidone

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionLong-acting formulation of risperidone
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT) receptor
Mechanism of ActionMonoaminergic receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today